Literature DB >> 2035534

Characterization of the molecular basis of the alpha 1-antitrypsin F allele.

H Okayama1, M Brantly, M Holmes, R G Crystal.   

Abstract

alpha 1-Antitrypsin (alpha 1AT), the major serum inhibitor of neutrophil elastase, is a highly polymorphic serum protein associated with characteristic isoelectric-focusing (IEF) patterns for most variants. To characterize the molecular basis of the anodal F variant, the DNA sequence of the coding exons of an FZ individual was determined. The F allele differed from the normal M1(Val213) alpha 1AT allele by a single nucleotide transversion of cytosine to thymidine, which results in the amino acid substitution Arg223 CGT----Cys TGT. Inheritance of the F mutation was confirmed by family analysis using allele-specific amplification. In the context that the normal alpha 1AT molecule has only one cysteine residue, a mutation resulting in the addition of a second cysteine may influence the three-dimensional form of the protein and/or permit interaction with other plasma proteins with free-SH groups and may be responsible for the observation that the major F alpha 1AT bands often migrate as doublets in IEF gels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2035534      PMCID: PMC1683089     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  25 in total

1.  Antitrypsin phenotypes in St. Louis.

Authors:  J A Pierce; B Eradio; T A Dew
Journal:  JAMA       Date:  1975-02-10       Impact factor: 56.272

Review 2.  The alpha 1-antitrypsin gene and its deficiency states.

Authors:  R G Crystal
Journal:  Trends Genet       Date:  1989-12       Impact factor: 11.639

3.  Antitrypsin deficiency and abnormal protease inhibitor phenotypes.

Authors:  C Mittman; T Barbela; J Lieberman
Journal:  Arch Environ Health       Date:  1973-09

4.  Serum prealbumin: polymorphism in man.

Authors:  M K Fagerhol; M Braend
Journal:  Science       Date:  1965-08-27       Impact factor: 47.728

5.  Report of Nomenclature Meeting for alpha 1-antitrypsin, INSERM, Rouen/Bois-Guillaume-1978.

Authors:  D W Cox; A M Johnson; M K Fagerhol
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

6.  Pi M4: an additional Pi M subtype.

Authors:  J Constans; M Viau; C Gouaillard
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

Review 7.  Structure and variation of human alpha 1-antitrypsin.

Authors:  R W Carrell; J O Jeppsson; C B Laurell; S O Brennan; M C Owen; L Vaughan; D R Boswell
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

8.  Disulphide bridges in globular proteins.

Authors:  J M Thornton
Journal:  J Mol Biol       Date:  1981-09-15       Impact factor: 5.469

9.  Pulmonary emphysema associated with the FZ alpha 1-antitrypsin phenotype.

Authors:  D W Cockcroft; R K Tennent; S L Horne
Journal:  Can Med Assoc J       Date:  1981-03-15       Impact factor: 8.262

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  7 in total

1.  Characterization of mutants of the vitamin D-binding protein/group-specific component: molecular evolution of GC*1A2 and GC*1A3, common in some Asian populations.

Authors:  I Yuasa; A Kofler; A Braun; K Umetsu; R Bichlmaier; S Kammerer; H Cleve
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

2.  Identification of compound heterozygous mutation in a Korean patient with alpha 1-antitrypsin deficiency.

Authors:  Dae-Hyun Ko; Ho Eun Chang; Sang Hoon Song; Hoil Yoon; Kyoung Un Park; Junghan Song
Journal:  Korean J Lab Med       Date:  2011-10-03

3.  Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels.

Authors:  Gian Andri Thun; Medea Imboden; Ilaria Ferrarotti; Ashish Kumar; Ma'en Obeidat; Michele Zorzetto; Margot Haun; Ivan Curjuric; Alexessander Couto Alves; Victoria E Jackson; Eva Albrecht; Janina S Ried; Alexander Teumer; Lorna M Lopez; Jennifer E Huffman; Stefan Enroth; Yohan Bossé; Ke Hao; Wim Timens; Ulf Gyllensten; Ozren Polasek; James F Wilson; Igor Rudan; Caroline Hayward; Andrew J Sandford; Ian J Deary; Beate Koch; Eva Reischl; Holger Schulz; Jennie Hui; Alan L James; Thierry Rochat; Erich W Russi; Marjo-Riitta Jarvelin; David P Strachan; Ian P Hall; Martin D Tobin; Morten Dahl; Sune Fallgaard Nielsen; Børge G Nordestgaard; Florian Kronenberg; Maurizio Luisetti; Nicole M Probst-Hensch
Journal:  PLoS Genet       Date:  2013-08-22       Impact factor: 5.917

4.  The significance of the F variant of alpha-1-antitrypsin and unique case report of a PiFF homozygote.

Authors:  Nicola Jane Sinden; Firas Koura; Robert Andrew Stockley
Journal:  BMC Pulm Med       Date:  2014-08-07       Impact factor: 3.317

5.  Characterisation of a type II functionally-deficient variant of alpha-1-antitrypsin discovered in the general population.

Authors:  Mattia Laffranchi; Emma L K Elliston; Fabrizio Gangemi; Romina Berardelli; David A Lomas; James A Irving; Annamaria Fra
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.752

Review 6.  Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum.

Authors:  Susana Seixas; Patricia Isabel Marques
Journal:  Appl Clin Genet       Date:  2021-03-22

7.  Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency.

Authors:  Irina Petrache; Joud Hajjar; Michael Campos
Journal:  Biologics       Date:  2009-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.